Interactions between antitumour agents and radiation and the expression of resistance (Q37063023)

18 August 2017

1 reference

title

Interactions between antitumour agents and radiation and the expression of resistance (English)

1 reference

18 August 2017

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

2 December 2022

author name string

B. T. Hill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1821327

2 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1821327

2 December 2022

publication date

1 September 1991

1 reference

full work available at URL

18 August 2017

https://api.elsevier.com/content/article/PII:030573729190006L?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

https://api.elsevier.com/content/article/PII:030573729190006L?httpAccept=text/plain

2 December 2022

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

2 December 2022

published in

Cancer Treatment Reviews

1 reference

18 August 2017

volume

18

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

149-190

1 reference

A human cell line from a pleural effusion derived from a breast carcinoma

18 August 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/51.5.1409

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/316820A0

Hypoxia-mediated drugs for radiation and chemotherapy

1

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung Group

2 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer

2 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

The independent action of radiation and cisplatin on the survival or recovery of human normal or tumour cells in vitro or in vivo

2 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity

2 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre-exposed in vitro to either X-irradiation or cisplatin.

2 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Cisplatin and radiation: interaction probabilities and therapeutic possibilities

2 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Effects of fractionated X-irradiation on subsequent response to acute X-irradiation in two human tumour cell lines in vitro

2 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Interaction between radiation and drug damage in mammalian cells. IV. Radiation response of adriamycin-resistant V79 cells.

2 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Doxorubicin decreases the repair of radiation-induced DNA damage

2 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Drug or radiation changes to the host which could affect the outcome of combined modality therapy

2 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells

2 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Effect of inhibitors of poly(ADP-ribose)polymerase on the radiation response of HeLa S3 cells

2 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Concomitant 5-fluorouracil infusion, mitomycin C and radical radiation therapy in esophageal squamous cell carcinoma

2 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma

2 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood

2 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

The initial slope of human tumor cell survival curves: its modification by the oxic cell sensitizer beta-arabinofuranosyladenine

2 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene

2 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma

2 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

2 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro

2 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Interaction between flavone acetic acid (LM-975, NSC 349512) and radiation in Glasgow's osteogenic sarcoma in vivo

2 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Interaction between the microtubule inhibitor tubulozole and gamma-irradiation in murine tumors in vivo

2 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Combined modality treatment of advanced cancers of the oral cavity and oropharynx

2 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Interleukin-1 modification of the effects of cyclophosphamide and fractionated irradiation

2 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Sequencing radiation and adriamycin exposures in spheroids to maximize therapeutic gain.

2 December 2022

36

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck

2 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Chemotherapy of testicular cancer

2 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma

2 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Interleukin-1 alpha protects against the toxicity associated with combined radiation and drug therapy

2 December 2022

40

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Recombinant murine GM-CSF increases resistance of some factor dependent hematopoietic progenitor cells to low-dose-rate gamma irradiation.

2 December 2022

41

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Early and late effects of mitomycin C and continuous low-dose-rate irradiation on the mouse skin and soft tissues of the leg.

2 December 2022

42

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Modification of the effects of continuous low dose rate irradiation by concurrent chemotherapy infusion

2 December 2022

43

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Rapidly alternating radiotherapy and high dose cisplatin chemotherapy in stage IIIB non-small cell lung cancer: Results of a phase I/II study

2 December 2022

44

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

The emerging biology of modern radiation oncology

2 December 2022

46

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Expression of the multidrug resistance, MDR1, gene in neuroblastomas

2 December 2022

47

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Expression of a multidrug resistance gene in human cancers

2 December 2022

48

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Radiosensitizing and cytotoxic properties of mitomycin C in a C3H mouse mammary carcinoma in vivo

2 December 2022

49

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

X-ray induction of methotrexate resistance due to dhfr gene amplification

2 December 2022

50

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

2 December 2022

Basic radiobiology.

51

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines

2 December 2022

52

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Mechanisms of X-ray-mediated protooncogene c-iun expression in radiation-induced human sarcoma cell lines

2 December 2022

53

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Effect of vincristine or bleomycin on radiation-induced cell killing of mice spermatogonial stem cells: The importance of sequence and time interval

2 December 2022

54

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer.

2 December 2022

55

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

The effect of fluorodeoxyuridine on sublethal damage repair in human colon cancer cells

2 December 2022

56

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies

2 December 2022

57

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Establishment of an etoposide-resistant human epithelial tumour cell line in vitro: characterization of patterns of cross-resistance and drug sensitivities

2 December 2022

65

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro.

2 December 2022

67

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

The role of adjuvant chemotherapy in the treatment of advanced head and neck cancer

2 December 2022

68

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Importance of primary site in assessing chemotherapy response and 7-year survival data in advanced squamous-cell carcinomas of the head and neck treated with initial combination chemotherapy without cisplatin

2 December 2022

69

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

24-hour combination chemotherapy without cisplatin in patients with recurrent or metastatic head and neck cancer

2 December 2022

70

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.

2 December 2022

71

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities

2 December 2022

72

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Establishment and characterisation of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies

2 December 2022

74

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Differential expression of drug resistance following in vitro exposure of human tumour cell lines to fractionated X-irradiation.

2 December 2022

75

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Interactions between antitumor drugs and radiation in mammalian tumor cell lines: differential drug responses and mechanisms of resistance following fractionated X-irradiation or continuous drug exposure in vitro

2 December 2022

76

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

A lack of detectable modification of topoisomerase II activity in a series of human tumor cell lines expressing only low levels of etoposide resistance

2 December 2022

77

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Isolation of a human teratoma cell line which expresses F9 antigen

2 December 2022

78

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Early and Late Changes in the Functional Vascularity of the Hamster Cheek Pouch after Local X-Irradiation

2 December 2022

80

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Drug resistance following irradiation of RIF-1 tumors: influence of the interval between irradiation and drug treatment.

2 December 2022

83

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Combined modality therapy using cytotoxic agents and radiation therapy

2 December 2022

84

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer

2 December 2022

85

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Concomitant evaluation of efficiency, acute and delayed toxicities of combined treatment of radiation and CDDP on an in vivo model

2 December 2022

86

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems

2 December 2022

87

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma.

2 December 2022

89

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Phase I and pharmacokinetic study of flavone acetic acid

2 December 2022

91

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Potentiation of radiation effects on multicellular tumor spheroids (MTS) of HeLa cells by lonidamine

2 December 2022

92

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Combination of radiation therapy and intracranial bleomycin in the 9L rat brain tumor model

2 December 2022

93

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses

2 December 2022

94

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Enhancement of sensitivity of human squamous carcinoma cells to radiation by epidermal growth factor

2 December 2022

95

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Epidermal growth factor modification of radioresistance related to cell-cell interactions

2 December 2022

96

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

DNA repair in drug resistance: studies on the repair process at the level of the gene

2 December 2022

100

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Differential patterns of anti-tumour drug responses and mechanisms of resistance in a series of independently-derived VP-16-resistant human tumour cell lines

2 December 2022

101

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Experimental and clinical studies alternating chemotherapy and radiotherapy

2 December 2022

102

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Rationale for different chemotherapeutic and radiation therapy strategies in cancer management

2 December 2022

103

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Metoclopramide enhances the effect of ionizing radiation on xenografted squamous cell carcinoma of the head and neck

2 December 2022

105

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Randomized study of 5 fluorouracil and cis platin as neoadjuvant therapy in head and neck cancer: a preliminary report

2 December 2022

106

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Overexpression of P-glycoprotein in human lung carcinoma xenografts after fractionated irradiation in vivo

2 December 2022

108

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Response of human tumor cell lines in vitro to fractionated irradiation

2 December 2022

110

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

The role of the H-ras oncogene in radiation resistance and metastasis

2 December 2022

112

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study

2 December 2022

113

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Tumor cell drug and radiation resistance: does an interrelationship exist?

2 December 2022

115

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC). Groupe Lyonnais d'Oncologie Thoracique

2 December 2022

116

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Radiation induction of drug resistance in RIF-1: correlation of tumor and cell culture results.

2 December 2022

117

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Multiple fractions of gamma rays induced resistance to cis-dichloro-diammineplatinum (II) and methotrexate in human HeLa cells.

2 December 2022

119

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Relation between responses to induction chemotherapy and subsequent radiotherapy in advanced or multicentric squamous cell carcinomas of the head and neck

2 December 2022

121

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Effectiveness of combined radio-chemotherapy in the management of epidermoid carcinoma of the anal canal

2 December 2022

123

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity

2 December 2022

124

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

The interaction of cisplatin plus etoposide with radiation +/- hyperthermia

2 December 2022

125

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

A kinetically based logical approach to the chemotherapy of head and neck cancer

2 December 2022

126

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy

2 December 2022

128

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (MO) disease

2 December 2022

129

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Synchronous cisplatin infusion during radiotherapy for the treatment of metastatic melanoma

2 December 2022

131

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion

2 December 2022

132

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder

2 December 2022

133

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining

2 December 2022

135

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Radiotherapy with and without cisplatin in bladder cancer

2 December 2022

136

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein

2 December 2022

137

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Cisplatin resistance in human cancers

2 December 2022

138

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups

2 December 2022

139

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Neoadjuvant chemotherapy in operable breast cancer

2 December 2022

140

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence

2 December 2022

141

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Faster repair of DNA double-strand breaks in radioresistant human tumor cells

2 December 2022

143

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Amplification and expression of genes associated with multidrug resistance in mammalian cells.

2 December 2022

144

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene

2 December 2022

146

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Radiation resistance in a multidrug resistant human T-cell leukemia line.

2 December 2022

147

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation

2 December 2022

149

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin

2 December 2022

151

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

New natural products in cancer chemotherapy

2 December 2022

152

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells

2 December 2022

153

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Modification of normal tissue response to radiotherapy and chemotherapy

2 December 2022

156

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Interaction of platinum(II) tetrachlorodianion (Fast Black)2 with superhelical DNA and with radiation in vitro and in vivo

2 December 2022

158

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Mutation induction and inactivation in mammalian cells exposed to ionising radiation

2 December 2022

160

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma

2 December 2022

161

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatin

2 December 2022

163

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cells

2 December 2022

164

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Time- and Sequence-dependent Responses to Cisplatin and Radiation in the Rat Kidney

2 December 2022

165

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Effect of simultaneous administration of bleomycin on the acute skin reactions of mice after single and fractionated doses of radiation

2 December 2022

166

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

An important step in radiation carcinogenesis may be inactivation of cellular genes.

2 December 2022

168

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy

2 December 2022

169

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Inherently radioresistant cells exist in some human tumors

2 December 2022

170

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Biological consequences of gene regulation after ionizing radiation exposure

2 December 2022

171

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer

2 December 2022

172

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

DNA excision repair in mammalian cell extracts

2 December 2022

175

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Tumor heterogeneity, tumor size, and radioresistance

2 December 2022

176

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

The response of hypoxic cells in SCCVII murine tumors to treatment with cisplatin and x rays

2 December 2022

177

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

The uptake of 3H-vincristine by a mouse carcinoma during a course of fractionated radiotherapy

2 December 2022

179

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

Combined chemotherapy--radiotherapy of anal cancer

2 December 2022

181

1 reference

https://api.crossref.org/works/10.1016/0305-7372(91)90006-L

2 December 2022

Identifiers

1 reference

18 August 2017

1 reference